Table 1 Availability of anti-malarial and malaria blood testing among all public sector outlets screened
Public health facility | CHW | Total public sectora | |
|---|---|---|---|
% (95% CI) | % (95% CI) | % (95% CI) | |
Availability of: | N = 298 | N = 145 | N = 536 |
Any anti-malarial | 95.0 (90.3, 97.4) | 59.4 (40.2, 76.1) | 72.6 (58.1, 83.5) |
Quality-assured ACT | 89.9 (83.9, 93.8) | 54.8 (32.2, 75.7) | 59.4 (43.6, 73.4) |
Quality ACT with the ‘green leaf’ logo | 3.0 (0.9, 9.8) | 0.6 (0.1, 4.3) | 4.7 (2.0, 10.8) |
Sulfadoxine–pyrimethamine | 73.9 (63.9, 81.9) | 0.0 (–) | 20.6 (14.9, 27.7) |
Oral quinine | 87.7 (82.7, 91.3) | 2.3 (0.4, 11.7) | 33.2 (25.0, 42.6) |
Chloroquine | 0.4 (0.1, 1.6) | 0.0 (–) | 1.3 (0.5, 3.5) |
Oral artemisinin monotherapy | 0.0 (–) | 0.0 (–) | 0.0 (–) |
Artesunate injection | 5.3 (1.6, 16.6) | 0.0 (–) | 1.3 (0.4, 4.1) |
Artemether injection | 6.2 (2.1, 16.7) | 0.0 (–) | 5.5 (2.5, 11.8) |
Quinine injection | 79.3 (69.5, 86.5) | 4.5 (0.8, 22.1) | 32.2 (23.9, 41.9) |
Availability of: | N = 298 | N = 145 | N = 536 |
Any diagnostic test | 94.7 (90.1, 97.2) | 68.4 (47.3, 84.0) | 69.4 (56.9, 79.6) |
Microscopy | 28.7 (21.4, 37.2) | 0.9 (0.1, 5.1) | 8.9 (6.0, 13.0) |
RDT | 94.4 (89.8, 96.9) | 68.4 (47.3, 84.0) | 68.3 55.8, 78.7) |
Readiness for malaria case management: | N = 298 | N = 145 | N = 536 |
Quality-assured ACT and malaria testing available | 89.0 (82.7, 93.2) | 49.7 (28.4, 71.2) | 53.7 (39.2, 67.6) |
Quality-assured ACT no malaria testing available | 1.0 (0.2, 3.6) | 5.1 (2.3, 11.0) | 5.7 (3.1, 10.2) |